These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 36650960)

  • 1. Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy.
    Yin W; Chang J; Sun J; Zhang T; Zhao Y; Li Y; Dong H
    J Mater Chem B; 2023 Feb; 11(6):1171-1190. PubMed ID: 36650960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic Nanomedicine-Mediated Ferroptosis: A Synergistic Approach to Combined Cancer Therapies and Immunotherapy.
    Mohapatra A; Mohanty A; Park IK
    Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance.
    Cai J; Xu X; Saw PE
    Sci China Life Sci; 2024 Jan; 67(1):19-40. PubMed ID: 37728804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.
    Yang H; Yao X; Liu Y; Shen X; Li M; Luo Z
    ACS Nano; 2023 Aug; 17(16):15328-15353. PubMed ID: 37573530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine.
    Su Y; Liu B; Wang B; Chan L; Xiong C; Lu L; Zhang X; Zhan M; He W
    Small; 2024 Jun; 20(25):e2310342. PubMed ID: 38221682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
    Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
    Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Macrophage-Ferroptosis Crosstalk: A Novel Insight into Tumor Immunotherapy.
    Zhou Z; Xu B; Hu N; Guo Z; Bao W; Shao B; Yang W
    Front Biosci (Landmark Ed); 2022 Jun; 27(7):203. PubMed ID: 35866391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy.
    Sandbhor P; Palkar P; Bhat S; John G; Goda JS
    Nanoscale; 2024 Mar; 16(13):6330-6364. PubMed ID: 38470224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and application of ferroptosis in cancer therapy.
    Nie Q; Hu Y; Yu X; Li X; Fang X
    Cancer Cell Int; 2022 Jan; 22(1):12. PubMed ID: 34996454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topology regulation of nanomedicine for autophagy-augmented ferroptosis and cancer immunotherapy.
    Hu R; Dai C; Dai X; Dong C; Huang H; Song X; Feng W; Ding L; Chen Y; Zhang B
    Sci Bull (Beijing); 2023 Jan; 68(1):77-94. PubMed ID: 36621435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects.
    Yu S; Tong L; Shen J; Li C; Hu Y; Feng K; Shao J
    Eur J Med Chem; 2024 Apr; 269():116290. PubMed ID: 38518522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine.
    Wang X; Hua P; He C; Chen M
    Acta Pharm Sin B; 2022 Sep; 12(9):3567-3593. PubMed ID: 36176912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress on nanomedicine-induced ferroptosis for cancer therapy.
    Zafar H; Raza F; Ma S; Wei Y; Zhang J; Shen Q
    Biomater Sci; 2021 Aug; 9(15):5092-5115. PubMed ID: 34160488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress on targeting ferroptosis for cancer therapy.
    Xu G; Wang H; Li X; Huang R; Luo L
    Biochem Pharmacol; 2021 Aug; 190():114584. PubMed ID: 33915157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy.
    Gu X; Liu Y; Dai X; Yang YG; Zhang X
    Front Immunol; 2023; 14():1137107. PubMed ID: 36926345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology.
    Yu Z; Mo Z; Qiu Y; Lu H; Zheng B; Liu L
    Curr Pharm Biotechnol; 2024; 25(15):2012-2021. PubMed ID: 38284738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics.
    Zhang X; Ma Y; Wan J; Yuan J; Wang D; Wang W; Sun X; Meng Q
    Front Chem; 2021; 9():768248. PubMed ID: 34869212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy.
    Zheng X; Jin X; Ye F; Liu X; Yu B; Li Z; Zhao T; Chen W; Liu X; Di C; Li Q
    Exp Hematol Oncol; 2023 Jul; 12(1):65. PubMed ID: 37501213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A promising new approach to cancer therapy: Manipulate ferroptosis by hijacking endogenous iron.
    Zhu L; Du Y
    Int J Pharm; 2024 Sep; 662():124517. PubMed ID: 39084581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches.
    Cheng X; Zhao F; Ke B; Chen D; Liu F
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.